Glaxo Agrees to Add Black Box Warning for Avandia

Avandia, the once popular diabetes drug, will receive a black box warning that the drug has “been associated with an increased risk of ischemic events such as heart attacks.” Glaxo did win out in that the warning states that all data remains inconclusive. The warning will be added to drug products that work in combination with Avandia.